Novo-Funded Analysis Ties Raising Ozempic to 2 mg to Slightly Lower Heart Risk Than Switching to Mounjaro
A Novo-funded claims analysis tied raising Ozempic to 2 mg with 6% lower heart risk than switching to Mounjaro. Here is why confounding matters.
Medical Daily ·